**HEADLINE: The Mangione Squeeze: Why a $90B Healthcare Giant Just Took a $2B Hit**

HEADLINE: The Mangione Squeeze: Why a $90B Healthcare Giant Just Took a $2B Hit

The Brief: Activist investor Luigi Mangione has executed a hostile shake-up at healthcare behemoth UnitedHealth, forcing an immediate $2B write-down on its Optum pharmacy division. The move signals a new era of “value enforcement” in Big Pharma.

The Impact:

• The Pivot: Mangione successfully argued that Optum’s PBM pricing model is a ticking liability, not a profit center. He forced a spin-off of the patient-data arm to prevent a regulatory “bloodbath.”
• The Play: The $2B charge funds a $1.5B stock buyback and a $500M “patient price rewind” program—directly cutting into UnitedHealth’s 10% annual premium increases.
• The Market: Sector analysts are downgrading major insurers. The “Mangione Squeeze” is becoming the new template for activist campaigns in healthcare.

Key Takeaway: Mangione isn’t just slashing costs; he’s weaponizing transparency. The lesson: If you don’t disrupt your own margin, someone else will.